Transcript Enterprise Search at AstraZeneca Pharmaceuticals

Enterprise Search at
AstraZeneca
Pharmaceuticals
General AstraZeneca Background
• Waltham focus on Cancer and Infection
• About 12,000 R&D Staff Globally
• Increasing External Partnerships and Alliances
Montreal
Boston
Internal Drug Projects
Patients & Markets
Organization & Admin
Mölndal
Alderley
Macclesfield
Södertälje
Lund
Charnwood
Avlon
Wilmington
Reims
2
More at AstraZeneca.com
Bangalore
Search in Context
Portal Interface:
Single point of entry
to information and
tools – via browsing
or searching
Information Libraries:
Collaborative Areas:
More official sources of “finished”
information that’s likely to have value over
time and to a relatively wide audience
Place to collaborate quickly and
easily without worrying about work in
progress being misunderstood
~ 8,000 today
Our “3-Fold Path”
3
Search Interfaces
4
Amateur’s View of Search
• Engine
• We Currently use Autonomy
• Constant Comparison to Speed & Quality of Google
• Interface
• Simple starting point – click and go
• Advanced option (rarely used)
• Presentation of Results
• Underlying Quality of Information
• Increasing Reach of Enterprise Taxonomy
• Very questionable application by individual editors /
contributors
5
Open Questions
• How can we reduce the IM burden on scientists,
clinicians?
•
•
Taxonomy vs Folksonomy vs Irrelevant
Will manual tagging of documents be overtaken by
technology?
• How to integrate it all
• Volume
• Range of repositories – secure, limited, and open
• Range of information types – structured, free, video,
etc.
• General People Issues
• Are people ready to find vs navigate?
• Dealing with range of skill levels & time constraints
6